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  Susumu KAGEyAMA and Tomohiro UEDA
From the．DePartment of Urology， Kouga Public HosPital
  A case of primary squamous cell carcinoma of the ureter is reported． A 62－year－old male
presented with gross hematuria and paralysis of the left leg． Abdominal computed tomographic （CT）
scan and ultra’s’onograPhy revealed left hydronephrosis， a massive tumor （8×7 cm） in the left distal
ureter which invaded the pelvic bone （T4）， and left obturator lymph node metastasis （N2）． Pathologic
examination of the．． biopsy specimen revealed poorly differentiated squamous cell carcinoma．
  Cisplatin （IOO mg／m2， day 1） and 5－fluorouracil （960 mg／m2／day， days 2－6） were administered
systemically in accordance with biochemical modulation regimen for head and neck squamous cell
carcinoma， and a minor response was obtained （tumor regression rate 380／o， serum SCC antigen
regression rate 640／o）． Thereafter， resection of residual tumor was performed， resulting in non－
curative operation Pecause ofdirect invasion to the pelvic bone． Four months after tumorectomy， liver
metastasis appeared， and the patient died of disease 14 months after the initial visit．
  Combination therapy with cisplatin and 5－fluorouracil is widely used for head and neck squamous
cell carcinoma， and the response rate has been reported to be 46－940／o． This regimen may also be
effective against urOlogical squamous cell carcinoma．
                               （Acta Urol． Jpn． 43： 41－44， 1997）”























 入院時検査所見：RBC 350×IO4／mm3， Hb 8．2
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Fig． 1．Abdominal CT scan revealed a tumor
to the left of the bladder．
Fig． 2． Microscopic examination of the biopsy
    specimen revealed a squamous cell
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